Novan Inc (NASDAQ:NOVN) VP John M. Gay acquired 14,900 shares of Novan stock in a transaction dated Friday, May 17th. The shares were acquired at an average price of $1.50 per share, with a total value of $22,350.00. Following the completion of the purchase, the vice president now owns 15,000 shares in the company, valued at $22,500. The purchase was disclosed in a filing with the SEC, which is available at the SEC website.
Shares of NASDAQ:NOVN opened at $1.86 on Wednesday. Novan Inc has a 52-week low of $0.65 and a 52-week high of $3.25.
A number of equities analysts have recently commented on NOVN shares. ValuEngine downgraded shares of Novan from a “hold” rating to a “sell” rating in a research note on Wednesday, May 1st. JMP Securities downgraded shares of Novan from an “outperform” rating to a “market perform” rating in a research note on Friday, March 29th. Finally, Zacks Investment Research downgraded shares of Novan from a “buy” rating to a “hold” rating in a research note on Tuesday, February 12th. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating and two have issued a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $4.33.
A number of large investors have recently modified their holdings of the stock. RMB Capital Management LLC raised its holdings in Novan by 45.5% in the 4th quarter. RMB Capital Management LLC now owns 32,000 shares of the company’s stock valued at $27,000 after acquiring an additional 10,000 shares during the period. Prospera Financial Services Inc raised its holdings in Novan by 44.3% in the 1st quarter. Prospera Financial Services Inc now owns 87,552 shares of the company’s stock valued at $79,000 after acquiring an additional 26,860 shares during the period. Bank of New York Mellon Corp bought a new position in Novan in the 4th quarter valued at about $25,000. Renaissance Technologies LLC raised its holdings in Novan by 52.0% in the 3rd quarter. Renaissance Technologies LLC now owns 89,700 shares of the company’s stock valued at $250,000 after acquiring an additional 30,700 shares during the period. Finally, Deutsche Bank AG raised its holdings in Novan by 4,462.7% in the 4th quarter. Deutsche Bank AG now owns 47,863 shares of the company’s stock valued at $39,000 after acquiring an additional 46,814 shares during the period. Institutional investors and hedge funds own 6.55% of the company’s stock.
WARNING: “Insider Buying: Novan Inc (NOVN) VP Buys 14,900 Shares of Stock” was published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international copyright and trademark law. The legal version of this report can be viewed at https://www.dispatchtribunal.com/2019/05/22/insider-buying-novan-inc-novn-vp-buys-14900-shares-of-stock.html.
Novan Company Profile
Novan, Inc, a clinical-stage biotechnology company, focuses on the development and commercialization of nitric oxide-based therapies to treat dermatological and oncovirus-mediated diseases. Its clinical stage product candidates include SB204, a topical monotherapy that is in Phase III pivotal clinical trials for the treatment of acne vulgaris; and SB206, a topical antiviral gel, which is in Phase III pivotal trials for the treatment of patients with external genital warts, and Phase II clinical trial for the treatment of molluscum contagiosum.
Recommended Story: How mutual funds make money
Receive News & Ratings for Novan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novan and related companies with MarketBeat.com's FREE daily email newsletter.